Driving value in phase IIIb & IV trials
Magnus Jaderberg, speaking at Late Phase Drug Development World Europe 2011

Magnus Jaderberg,
Chief Medical Officer, Europe
BMS

Pharmaceutical physician with over 20 years in various R/D functions including clinical research, medical affairs, pharmacovigilance, strategic product development and general management. Lecturer in drug development at King’s College, London.
Appearing:
Day One- Wednesday 7th December 2011
12pm

MANAGING THE EXPECTATIONS OF PHYSICIANS AND PATIENTS DURING THE PERIOD BETWEEN PHASE III AND REGULATORY APPROVAL – A CASE STUDY

Magnus Jaderberg,
Chief Medical Officer, Europe,
BMS
Register Now! »

Sponsor Late Phase Drug Development World Europe 2011 ›

Premium sponsor
PAREXEL International at Late Phase Drug Development World Europe 2011
Session Facilitator
PharmaNet Ltd at Late Phase Drug Development World Europe 2011
Session Facilitator
PRA International at Late Phase Drug Development World Europe 2011
Session Facilitator
United BioSource Corporation at Late Phase Drug Development World Europe 2011
Session Presentation
Medidata Solutions Inc at Late Phase Drug Development World Europe 2011
Session Presentation
Oracle Corporation UK Limited at Late Phase Drug Development World Europe 2011
Exhibitor
CRL Corp at Late Phase Drug Development World Europe 2011
Exhibitor
PHT Corporation Sarl at Late Phase Drug Development World Europe 2011
sponsors list ›

Late Phase Drug Development World Europe 2011 is a multi-faceted event

  • A two day conference
  • A showcase
  • Case studies by industry professionals
  • Speed networking
  • Interactive panel discussions
  • Roundtable brainstorms
  • Live debates

Register now ›

You may also like to attend:

  • Late Phase Drug Development World Americas  
  • World Drug Safety Congress Europe
  • World Drug Safety Congress Americas
  • Clinical Outsourcing World Europe 

See more ›

We run training courses on:

  • 3 Day MBA in Pharmaceuticals

See more ›